Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume

Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume

US Patent 6688304 · Granted Feb 10, 2004

Estimated economic value: $2,064,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2023
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2023
Metabolism resistant fenfluramine analogs and methods of using the same2023
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2022
Metabolism resistant fenfluramine analogs and methods of using the same2022
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2021
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2021
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2020
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2019
Peptide particle formulation2019
Inhaled surfactant-modified liposomal formulations providing both an immediate a2018
Liposomal formulations that form drug nanocrystals after freeze-thaw2018